BD, ten23 health to Roll Out Prefillable Syringes with RFID Capabilities
With the implementation of unit-level traceability, the collaboration is expected to provide additional visibility not only within the aseptic manufacturing process, but the entire supply chain overall.
BD (Becton, Dickinson and Company), a medical technology company, and ten23 health, a Swiss contract development and manufacturing organization (CDMO), are teaming up to design a new way to track prefillable syringes (PFS) with the help of radio frequency identification (RFID) technology.1
The objective of the partnership is to test out an RFID-based solution designed by BD to that is expected to augment and add efficiencies to the manufacturing process, while also providing unit-level traceability. In turn, ten23 health customers will be able to experience greater traceability, not only throughout the entire manufacturing process, but within the supply chain overall.
Being coined BD iDFill Individual Prefillable Syringe Identification, in order for this effort to successful, each PFS must be equipped with an RFID tag that’s programmed with a unique serial number known as the container unique identifier (CUID), which is able to be scanned at multiple steps of the manufacturing process. All the necessary drug codes, filling batches, and timestamps—along with other data—are linked with the CUID, which activates that traceability factor.
“BD iDFill aims to transform the way we approach quality and efficiency in the fill & finish process by extending the role of the PFS from a drug container to a digital enabler,” said Patrick Jeukenne, president of BD Medical - Pharmaceutical Systems. “We expect this innovation will harness the vast potential of data in manufacturing and bring a new level of transparency to the pharmaceutical fill & finish process.”
This partnership also supports ten23 health’s interest in pursuing high-quality ventures.
“We are excited about this collaboration with BD, as it aligns perfectly with our commitment to innovation and quality,” said Hanns-Christian Mahler, CEO of ten23 health, whose company burst onto the scene back in 2021.2
References
1. BD and ten23 health partner to advance efficiency and quality in aseptic manufacturing with RFID-enabled prefillable syringes. BD. October 8, 2024. Accessed October 8, 2024. https://news.bd.com/2024-10-08-BD-and-ten23-health-R-partner-to-advance-efficiency-and-quality-in-aseptic-manufacturing-with-RFID-enabled-prefillable-syringes
2. New CDMO, ten23 health, joins the biopharma industry. Pharmaceutical Commerce. September 2, 2021. Accessed October 8, 2024. https://www.pharmaceuticalcommerce.com/view/new-cdmo-ten23-health-joins-the-biopharma-industry
